Home » Supreme Court Rejects Generic Challenge to Otsuka’s Abilify Patent
Supreme Court Rejects Generic Challenge to Otsuka’s Abilify Patent
The U.S. Supreme Court on refused to consider a generic-drug maker’s challenge to Otsuka Pharmaceutical’s U.S. patent for the blockbuster antipsychotic drug Abilify (aripiprazole).
Fox Business
Fox Business
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May